Advertisement

PharmacoEconomics & Outcomes News

, Volume 403, Issue 1, pp 3–5 | Cite as

First-line imatinib mesylate worth it in CML

Meeting report
  • 7 Downloads

Keywords

Imatinib Chronic Myeloid Leukaemia Cytarabine Chronic Phase Imatinib Mesylate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Adis International Ltd 2003

Personalised recommendations